生物製剤CDMOのグローバル市場2023~2027:哺乳類、微生物

【英語タイトル】Global Biologics CDMO Market 2023-2027

Technavioが出版した調査資料(IRTNTR72001-23)・商品コード:IRTNTR72001-23
・発行会社(調査会社):Technavio
・発行日:2023年2月2日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア太平洋、その他地域
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の本調査レポートによると、世界の生物製剤CDMO市場規模が2022年から2027年の間に132.6億ドルに達すると予測されており、予測期間中に年平均13.97%成長すると見込まれます。本書では生物製剤CDMOの世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、種類別(哺乳類、微生物)分析、製品種類別(生物製剤、バイオシミラー)分析、顧客状況、地域別状況(北米、アジア太平洋、ヨーロッパ、中東・アフリカ、南米、アメリカ、中国、ドイツ、イギリス、日本)分析、成長要因・課題・動向、企業状況、企業分析などの内容を掲載しています。なお、本書には、3P BIOPHARMACEUTICALS S.L.U., AbbVie Inc., AGC Biologics, Binex Co. Ltd., Boehringer Ingelheim International GmbH, Bora Pharmaceuticals Co. Ltd., Catalent Inc., Cytovance Biologics, Evonik Industries AG, FUJIFILM Holdings Corpなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析

・世界の生物製剤CDMO市場規模:製品別
- 哺乳類の市場規模
- 微生物の市場規模

・世界の生物製剤CDMO市場規模:製品種類別
- 生物製剤の市場規模
- バイオシミラーの市場規模

・顧客状況
・地域別状況
- 北米の生物製剤CDMO市場規模
- ヨーロッパの生物製剤CDMO市場規模
- アジア太平洋の生物製剤CDMO市場規模
- その他地域の生物製剤CDMO市場規模
- アメリカの生物製剤CDMO市場規模
- カナダの生物製剤CDMO市場規模
- ドイツの生物製剤CDMO市場規模
- イギリスの生物製剤CDMO市場規模
- 日本の生物製剤CDMO市場規模

・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、生物製剤CDMO市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、正確な生物製剤CDMO市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

生物製剤CDMOの世界市場 2023-2027

Technavio社は、生物製剤CDMO市場をモニターしており、2022年から2027年にかけて132.6億ドルの成長が予測され、予測期間中のCAGRは13.97%で加速すると予測しています。当レポートでは、生物製剤CDMO市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。新興市場におけるコスト効率の高いリソースの利用可能性、生物製剤治療薬の強力な研究開発パイプライン、コアコンピタンスに集中する必要性の高まりなどが市場を牽引しています。

Technavioの生物製剤CDMO市場は以下のように区分されます:

・タイプ別:
– 哺乳類
– 微生物

・製品タイプ別:
– 生物製剤
– バイオシミラー

・地域別:
– 北米
– ヨーロッパ
– アジア
– その他の地域(ROW)

本調査では、ビッグデータの出現が今後数年間の生物製剤CDMO市場の成長を促進する主な理由の1つであると特定しています。また、製薬企業との戦略的提携やパートナーシップ、新規分子やバイオシミラーの承認の増加が、市場の大きな需要につながるとしています。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

生物製剤CDMO市場に関する弊社のレポートは以下の分野をカバーしています:
– 生物製剤CDMO市場のサイジング
– 生物製剤CDMO市場の予測
– 生物製剤CDMO市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、3P BIOPHARMACEUTICALS S.L.U., AbbVie Inc., AGC Biologics, Binex Co. Ltd., Boehringer Ingelheim International GmbH, Bora Pharmaceuticals Co. Ltd., Catalent Inc., Cytovance Biologics, Evonik Industries AG, FUJIFILM Holdings Corp, Grifols SA, JRS PHARMA GmbH and Co. KG, JSR Corp., Kemwell Biopharma Pvt. Ltd., KLOCKE GROUP, Lonza Group Ltd., Novartis AG, Rentschler Biopharma SE, Samsung Biologics Co. Ltd., Toyobo Co. Ltd., and WuXi Biologics Cayman Incなどの企業情報が含まれています。また、生物製剤CDMO市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global biologics CDMO market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global biologics CDMO market 2017 – 2021 ($ billion)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
o 4.3 Product type Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product type Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Mammalian – Market size and forecast 2022-2027
o Exhibit 34: Chart on Mammalian – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Mammalian – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Mammalian – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Mammalian – Year-over-year growth 2022-2027 (%)
o 6.4 Microbial – Market size and forecast 2022-2027
o Exhibit 38: Chart on Microbial – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Microbial – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Microbial – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Microbial – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ billion)
• 7 Market Segmentation by Product Type
o 7.1 Market segments
o Exhibit 43: Chart on Product Type – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Product Type – Market share 2022-2027 (%)
o 7.2 Comparison by Product Type
o Exhibit 45: Chart on Comparison by Product Type
o Exhibit 46: Data Table on Comparison by Product Type
o 7.3 Biologics – Market size and forecast 2022-2027
o Exhibit 47: Chart on Biologics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Data Table on Biologics – Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Chart on Biologics – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Biologics – Year-over-year growth 2022-2027 (%)
o 7.4 Biosimilars – Market size and forecast 2022-2027
o Exhibit 51: Chart on Biosimilars – Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Data Table on Biosimilars – Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Chart on Biosimilars – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Biosimilars – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product Type
o Exhibit 55: Market opportunity by Product Type ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share by geography 2022-2027 (%)
o Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 81: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 82: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 83: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 89: Chart on France – Market size and forecast 2022-2027 ($ billion)
o Exhibit 90: Data Table on France – Market size and forecast 2022-2027 ($ billion)
o Exhibit 91: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 93: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 94: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 95: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 97: Market opportunity by geography ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 104: AbbVie Inc. – Overview
o Exhibit 105: AbbVie Inc. – Product / Service
o Exhibit 106: AbbVie Inc. – Key news
o Exhibit 107: AbbVie Inc. – Key offerings
o 12.4 Binex Co. Ltd.
o Exhibit 108: Binex Co. Ltd. – Overview
o Exhibit 109: Binex Co. Ltd. – Product / Service
o Exhibit 110: Binex Co. Ltd. – Key offerings
o 12.5 Boehringer Ingelheim International GmbH
o Exhibit 111: Boehringer Ingelheim International GmbH – Overview
o Exhibit 112: Boehringer Ingelheim International GmbH – Business segments
o Exhibit 113: Boehringer Ingelheim International GmbH – Key news
o Exhibit 114: Boehringer Ingelheim International GmbH – Key offerings
o Exhibit 115: Boehringer Ingelheim International GmbH – Segment focus
o 12.6 Bora Pharmaceuticals Co. Ltd.
o Exhibit 116: Bora Pharmaceuticals Co. Ltd. – Overview
o Exhibit 117: Bora Pharmaceuticals Co. Ltd. – Product / Service
o Exhibit 118: Bora Pharmaceuticals Co. Ltd. – Key offerings
o 12.7 Catalent Inc.
o Exhibit 119: Catalent Inc. – Overview
o Exhibit 120: Catalent Inc. – Business segments
o Exhibit 121: Catalent Inc. – Key news
o Exhibit 122: Catalent Inc. – Key offerings
o Exhibit 123: Catalent Inc. – Segment focus
o 12.8 Evonik Industries AG
o Exhibit 124: Evonik Industries AG – Overview
o Exhibit 125: Evonik Industries AG – Business segments
o Exhibit 126: Evonik Industries AG – Key news
o Exhibit 127: Evonik Industries AG – Key offerings
o Exhibit 128: Evonik Industries AG – Segment focus
o 12.9 FUJIFILM Holdings Corp
o Exhibit 129: FUJIFILM Holdings Corp – Overview
o Exhibit 130: FUJIFILM Holdings Corp – Business segments
o Exhibit 131: FUJIFILM Holdings Corp – Key offerings
o Exhibit 132: FUJIFILM Holdings Corp – Segment focus
o 12.10 Grifols SA
o Exhibit 133: Grifols SA – Overview
o Exhibit 134: Grifols SA – Business segments
o Exhibit 135: Grifols SA – Key offerings
o Exhibit 136: Grifols SA – Segment focus
o 12.11 JRS PHARMA GmbH and Co. KG
o Exhibit 137: JRS PHARMA GmbH and Co. KG – Overview
o Exhibit 138: JRS PHARMA GmbH and Co. KG – Product / Service
o Exhibit 139: JRS PHARMA GmbH and Co. KG – Key offerings
o 12.12 Lonza Group Ltd.
o Exhibit 140: Lonza Group Ltd. – Overview
o Exhibit 141: Lonza Group Ltd. – Business segments
o Exhibit 142: Lonza Group Ltd. – Key news
o Exhibit 143: Lonza Group Ltd. – Key offerings
o Exhibit 144: Lonza Group Ltd. – Segment focus
o 12.13 Novartis AG
o Exhibit 145: Novartis AG – Overview
o Exhibit 146: Novartis AG – Business segments
o Exhibit 147: Novartis AG – Key offerings
o Exhibit 148: Novartis AG – Segment focus
o 12.14 Rentschler Biopharma SE
o Exhibit 149: Rentschler Biopharma SE – Overview
o Exhibit 150: Rentschler Biopharma SE – Product / Service
o Exhibit 151: Rentschler Biopharma SE – Key offerings
o 12.15 Samsung Biologics Co. Ltd.
o Exhibit 152: Samsung Biologics Co. Ltd. – Overview
o Exhibit 153: Samsung Biologics Co. Ltd. – Product / Service
o Exhibit 154: Samsung Biologics Co. Ltd. – Key offerings
o 12.16 Toyobo Co. Ltd.
o Exhibit 155: Toyobo Co. Ltd. – Overview
o Exhibit 156: Toyobo Co. Ltd. – Business segments
o Exhibit 157: Toyobo Co. Ltd. – Key offerings
o Exhibit 158: Toyobo Co. Ltd. – Segment focus
o 12.17 WuXi Biologics Cayman Inc.
o Exhibit 159: WuXi Biologics Cayman Inc. – Overview
o Exhibit 160: WuXi Biologics Cayman Inc. – Product / Service
o Exhibit 161: WuXi Biologics Cayman Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 162: Inclusions checklist
o Exhibit 163: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 164: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 165: Research methodology
o Exhibit 166: Validation techniques employed for market sizing
o Exhibit 167: Information sources
o 13.5 List of abbreviations
o Exhibit 168: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Product Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global biologics CDMO market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Product type Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Mammalian – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Mammalian – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Mammalian – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Mammalian – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Microbial – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Microbial – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Microbial – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Microbial – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ billion)
Exhibits43: Chart on Product Type – Market share 2022-2027 (%)
Exhibits44: Data Table on Product Type – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Product Type
Exhibits46: Data Table on Comparison by Product Type
Exhibits47: Chart on Biologics – Market size and forecast 2022-2027 ($ billion)
Exhibits48: Data Table on Biologics – Market size and forecast 2022-2027 ($ billion)
Exhibits49: Chart on Biologics – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Biologics – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Biosimilars – Market size and forecast 2022-2027 ($ billion)
Exhibits52: Data Table on Biosimilars – Market size and forecast 2022-2027 ($ billion)
Exhibits53: Chart on Biosimilars – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Biosimilars – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Product Type ($ billion)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share by geography 2022-2027 (%)
Exhibits58: Data Table on Market share by geography 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits62: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits63: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits66: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits67: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits78: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits79: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits82: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits83: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on France – Market size and forecast 2022-2027 ($ billion)
Exhibits90: Data Table on France – Market size and forecast 2022-2027 ($ billion)
Exhibits91: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits94: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits95: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity by geography ($ billion)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: AbbVie Inc. – Overview
Exhibits105: AbbVie Inc. – Product / Service
Exhibits106: AbbVie Inc. – Key news
Exhibits107: AbbVie Inc. – Key offerings
Exhibits108: Binex Co. Ltd. – Overview
Exhibits109: Binex Co. Ltd. – Product / Service
Exhibits110: Binex Co. Ltd. – Key offerings
Exhibits111: Boehringer Ingelheim International GmbH – Overview
Exhibits112: Boehringer Ingelheim International GmbH – Business segments
Exhibits113: Boehringer Ingelheim International GmbH – Key news
Exhibits114: Boehringer Ingelheim International GmbH – Key offerings
Exhibits115: Boehringer Ingelheim International GmbH – Segment focus
Exhibits116: Bora Pharmaceuticals Co. Ltd. – Overview
Exhibits117: Bora Pharmaceuticals Co. Ltd. – Product / Service
Exhibits118: Bora Pharmaceuticals Co. Ltd. – Key offerings
Exhibits119: Catalent Inc. – Overview
Exhibits120: Catalent Inc. – Business segments
Exhibits121: Catalent Inc. – Key news
Exhibits122: Catalent Inc. – Key offerings
Exhibits123: Catalent Inc. – Segment focus
Exhibits124: Evonik Industries AG – Overview
Exhibits125: Evonik Industries AG – Business segments
Exhibits126: Evonik Industries AG – Key news
Exhibits127: Evonik Industries AG – Key offerings
Exhibits128: Evonik Industries AG – Segment focus
Exhibits129: FUJIFILM Holdings Corp – Overview
Exhibits130: FUJIFILM Holdings Corp – Business segments
Exhibits131: FUJIFILM Holdings Corp – Key offerings
Exhibits132: FUJIFILM Holdings Corp – Segment focus
Exhibits133: Grifols SA – Overview
Exhibits134: Grifols SA – Business segments
Exhibits135: Grifols SA – Key offerings
Exhibits136: Grifols SA – Segment focus
Exhibits137: JRS PHARMA GmbH and Co. KG – Overview
Exhibits138: JRS PHARMA GmbH and Co. KG – Product / Service
Exhibits139: JRS PHARMA GmbH and Co. KG – Key offerings
Exhibits140: Lonza Group Ltd. – Overview
Exhibits141: Lonza Group Ltd. – Business segments
Exhibits142: Lonza Group Ltd. – Key news
Exhibits143: Lonza Group Ltd. – Key offerings
Exhibits144: Lonza Group Ltd. – Segment focus
Exhibits145: Novartis AG – Overview
Exhibits146: Novartis AG – Business segments
Exhibits147: Novartis AG – Key offerings
Exhibits148: Novartis AG – Segment focus
Exhibits149: Rentschler Biopharma SE – Overview
Exhibits150: Rentschler Biopharma SE – Product / Service
Exhibits151: Rentschler Biopharma SE – Key offerings
Exhibits152: Samsung Biologics Co. Ltd. – Overview
Exhibits153: Samsung Biologics Co. Ltd. – Product / Service
Exhibits154: Samsung Biologics Co. Ltd. – Key offerings
Exhibits155: Toyobo Co. Ltd. – Overview
Exhibits156: Toyobo Co. Ltd. – Business segments
Exhibits157: Toyobo Co. Ltd. – Key offerings
Exhibits158: Toyobo Co. Ltd. – Segment focus
Exhibits159: WuXi Biologics Cayman Inc. – Overview
Exhibits160: WuXi Biologics Cayman Inc. – Product / Service
Exhibits161: WuXi Biologics Cayman Inc. – Key offerings
Exhibits162: Inclusions checklist
Exhibits163: Exclusions checklist
Exhibits164: Currency conversion rates for US$
Exhibits165: Research methodology
Exhibits166: Validation techniques employed for market sizing
Exhibits167: Information sources
Exhibits168: List of abbreviations



★調査レポート[生物製剤CDMOのグローバル市場2023~2027:哺乳類、微生物] (コード:IRTNTR72001-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[生物製剤CDMOのグローバル市場2023~2027:哺乳類、微生物]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆